# A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

> **NCT06171113** · PHASE1 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 156 (estimated)

## Conditions studied

- Malaria, Falciparum

## Interventions

- **DRUG:** GSK4024484C
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06171113
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-11
- **Primary completion:** 2026-08-07
- **Final completion:** 2026-08-07
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06171113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06171113, "A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06171113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*